Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies.

Gotoh M, Yoshizawa S, Katagiri S, Suguro T, Asano M, Kitahara T, Akahane D, Okabe S, Tauchi T, Ito Y, Ohyashiki K.

Bone Marrow Transplant. 2014 Jul;49(7):955-60. doi: 10.1038/bmt.2014.66. Epub 2014 Apr 14.

PMID:
24732960
2.

[Unrelated umbilical cord blood transplantation with TBI/Ara-c/CY non-ATG conditioning regimen for adults with hematologic malignancies].

Sun ZM, Liu HL, Geng LQ, Zhou CY, Wang XB, Ding KY, Tong J, Zhu WB, Liu X, Wang ZY.

Zhonghua Yi Xue Za Zhi. 2012 Jun 26;92(24):1660-4. Chinese.

PMID:
22944153
3.

Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.

Okada M, Fujimori Y, Misawa M, Kai S, Nakajima T, Okikawa Y, Satake A, Itoi H, Takatsuka H, Itsukuma T, Nishioka K, Tamaki H, Ikegame K, Hara H, Ogawa H.

Biol Blood Marrow Transplant. 2008 Aug;14(8):896-903. doi: 10.1016/j.bbmt.2008.05.020.

4.

Purine nucleoside analogues in the treatment of myleoid leukemias.

Robak T.

Leuk Lymphoma. 2003 Mar;44(3):391-409. Review.

PMID:
12688309
5.

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.

Gürman G, Arat M, Ilhan O, Konuk N, Beksaç M, Celebi H, Ozcan M, Arslan O, Ustün C, Akan H, Uysal A, Koç H.

Cytotherapy. 2001;3(4):253-60.

PMID:
12171713
6.

[Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].

Sun ZM, Liu HL, Wu Y, Geng LQ, Zheng CC, Tang BL, Zhu XY, Tong J, Wang XB, Ding KY, Wan X, Zhang L, Yao W, Zhang XH, Han YS, Yang HZ, Liu X, Zhu WW, Wu JS, Wang ZY.

Zhonghua Yi Xue Za Zhi. 2016 Jul 26;96(28):2214-9. doi: 10.3760/cma.j.issn.0376-2491.2016.28.003. Chinese.

PMID:
27480651
7.
8.

Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in Japan.

Konuma T, Takahashi S, Uchida N, Kuwatsuka Y, Yamasaki S, Aoki J, Onishi Y, Aotsuka N, Ohashi K, Mori T, Masuko M, Nakamae H, Miyamura K, Kato K, Atsuta Y, Kato S, Asano S, Takami A, Miyazaki Y; Adult Myelodysplastic Syndrome and Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1632-40. doi: 10.1016/j.bbmt.2015.05.009. Epub 2015 May 16.

9.

Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.

Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.

Biol Blood Marrow Transplant. 2008 Jun;14(6):651-7. doi: 10.1016/j.bbmt.2008.03.006.

10.

Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation.

Tomonari A, Takahashi S, Ooi J, Nakaoka T, Takasugi K, Uchiyama M, Tsukada N, Konuma T, Iseki T, Tojo A, Asano S.

Eur J Haematol. 2006 Jul;77(1):46-50. Epub 2006 Mar 27.

PMID:
16573743
11.

Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission.

Konuma T, Kato S, Ooi J, Oiwa-Monna M, Ebihara Y, Mochizuki S, Yuji K, Ohno N, Kawamata T, Jo N, Yokoyama K, Uchimaru K, Asano S, Tojo A, Takahashi S.

Biol Blood Marrow Transplant. 2014 Mar;20(3):396-401. doi: 10.1016/j.bbmt.2013.12.555. Epub 2013 Dec 11.

12.

Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.

Walker AR, Komrokji RS, Ifthikharuddin J, Messina P, Mulford D, Becker M, Friedberg J, Oliva J, Phillips G, Liesveld JL, Abboud C.

Leuk Res. 2008 Dec;32(12):1830-6. doi: 10.1016/j.leukres.2008.04.026. Epub 2008 Jun 20.

PMID:
18571721
13.

Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.

Petropoulos D, Worth LL, Mullen CA, Madden R, Mahajan A, Choroszy M, Ha CS, Champlin RC, Chan KW.

Bone Marrow Transplant. 2006 Mar;37(5):463-7.

PMID:
16435013
15.

[FLAG regimen as consolidation therapy for patients with acute myeloid leukemia].

Qian SX, Wu HX, Hong M, Lu H, Xu W, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Dec;17(6):1577-81. Chinese.

PMID:
20030951
16.

Recombinant human granulocyte colony-stimulating factor (G-CSF) combined conditioning regimen for allogeneic bone marrow transplantation (BMT) in standard-risk myeloid leukemia.

Takahashi S, Oshima Y, Okamoto S, Nishiwaki K, Nagayama H, Inoue T, Tojo A, Tani K, Asano S.

Am J Hematol. 1998 Apr;57(4):303-8.

17.

Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine.

Pabst T, Vellenga E, van Putten W, Schouten HC, Graux C, Vekemans MC, Biemond B, Sonneveld P, Passweg J, Verdonck L, Legdeur MC, Theobald M, Jacky E, Bargetzi M, Maertens J, Ossenkoppele GJ, Löwenberg B; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON); German AML Study Group (AMLSG); Swiss Collaborative Group for Clinical Cancer Research (SAKK).

Blood. 2012 Jun 7;119(23):5367-73. doi: 10.1182/blood-2011-11-389841. Epub 2012 Mar 15.

18.

[Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].

Meng FY, Yang LJ, Xu B, Liu XL, Zheng WY, Zhang Y, Huang F, Sun J, Liu QF.

Ai Zheng. 2003 Dec;22(12):1330-3. Chinese.

PMID:
14693062
19.

[Induction of Ph-negative normal clone and long-term survival by combined treatment with G-CSF plus middle dose cytosine arabinoside for patients with chronic myeloid leukemia in blastic transformation].

Katagiri T, Miyazawa K, Uchida Y, Hayashi S, Iwama H, Shyohji N, Kawakubo K, Shimamoto T, Inatomi Y, Kuriyama Y, Yaguchi M, Nehashi Y, Ohyashiki K, Toyama K.

Rinsho Ketsueki. 1998 Dec;39(12):1149-56. Japanese.

PMID:
10028846
20.

Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.

Kantarjian HM, Talpaz M, Kontoyiannis D, Gutterman J, Keating MJ, Estey EH, O'Brien S, Rios MB, Beran M, Deisseroth A.

J Clin Oncol. 1992 Mar;10(3):398-405.

PMID:
1740679

Supplemental Content

Support Center